Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FOS | P01100 | 1/20 | 0.65 |
| ▸ | TTR | P02766 | 1/20 | 0.65 |
| ▸ | JUN | P05412 | 1/20 | 0.65 |
| ▸ | NR3C1 | P04150 | 1/20 | 0.65 |
| ▸ | HSD17B1 | P14061 | 1/20 | 0.65 |
| ▸ | HSD17B2 | P37059 | 1/20 | 0.65 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.59 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.59 |
| ▸ | PTPN1 | P18031 | 2/20 | 0.58 |
| ▸ | TAAR1 | Q96RJ0 | 2/20 | 0.57 |
| ▸ | TSHR | P16473 | 2/20 | 0.57 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.57 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.57 |
| ▸ | MMP1 | P03956 | 1/20 | 0.57 |
| ▸ | LMNA | P02545 | 1/20 | 0.56 |
| ▸ | GLA | P06280 | 1/20 | 0.56 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.54 |
| ▸ | GAA | P10253 | 1/20 | 0.54 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.54 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.54 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31512875 | 1.00 | FOS (0.65) | FOSTTRJUNNR3C1HSD17B1 | |
| SCHEMBL31512868 | 0.87 | FOS (0.66) | FOSTTRJUNNR3C1HSD17B1 | |
| SCHEMBL21402282 | 0.86 | ALOX15 (0.65) | FOSTTRJUNNR3C1HSD17B1 | |
| SCHEMBL31512870 | 0.85 | FOS (0.59) | FOSTTRJUNNR3C1HSD17B1 | |
| SCHEMBL25586653 | 0.85 | CYP3A4 (0.60) | FOSTTRJUNNR3C1HSD17B1 | |
| SCHEMBL31512864 | 0.84 | FOS (0.58) | FOSTTRJUNNR3C1HSD17B1 | |
| SCHEMBL19129605 | 0.84 | CA2 (0.59) | ALOX15ALOX12CYP3A4ALDH1A1 | |
| SCHEMBL31512862 | 0.83 | FOS (0.57) | FOSTTRJUNNR3C1HSD17B1 | |
| SCHEMBL3156186 | 0.83 | ALDH1A1 (0.49) | FOSTTRJUNNR3C1HSD17B1 | |
| SCHEMBL31512872 | 0.83 | FOS (0.56) | FOSTTRJUNNR3C1HSD17B1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1285 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4410937-A2 | HOUSEHOLD PRODUCT DELIVERING WARMING AND/OR TINGLING SENSATIONS | Takasago International Corporation (JP) | 2024-08-07 | — | — | EP | claimed |
| EP-3494104-B1 | WARMING SENSATION COMPOUNDS | TAKASAGO PERFUMERY CO LTD (JP) | 2023-11-15 | — | — | EP | claimed |
| CN-115721567-A | Thermal wet tissue and preparation method thereof | 芜湖悠派护理用品科技股份有限公司 | 2023-03-03 | — | — | CN | claimed |
| EP-3569671-B1 | METHYLMENTHOL DERIVATIVE AND COOL-SENSATION IMPARTER COMPOSITION CONTAINING SAME | TAKASAGO PERFUMERY CO LTD (JP) | 2022-06-22 | — | — | EP | claimed |
| US-11344488-B2 | Cool-sensation imparter composition containing 2,2,6-trimethylcyclohexanecarboxylic acid derivative | TAKASAGO INTERNATIONAL CORPORATION (JP) | 2022-05-31 | — | — | US | claimed |
| CN-110168038-B | Methyl menthol derivative and cold sensate composition containing same | 高砂香料工业株式会社 | 2022-05-27 | — | — | CN | claimed |
| CN-109803948-B | Warming sensation compound | 高砂香料工业株式会社 | 2022-03-01 | — | — | CN | claimed |
| US-11236042-B2 | Methylmenthol derivative and cool-sensation imparter composition containing same | TAKASAGO INTERNATIONAL CORPORATION (JP) | 2022-02-01 | — | — | US | claimed |
| CN-113389055-A | Cool or heat-sensitive microcapsule, nonwoven fabric and absorbent article | 上海护理佳实业有限公司 | 2021-09-14 | — | — | CN | claimed |
| US-20210236678-A1 | HOUSEHOLD PRODUCT DELIVERING WARMING AND/OR TINGLING SENSATIONS | TAKASAGO INTERNATIONAL CORPORATION (JP) | 2021-08-05 | — | — | US | claimed |
| EP-0977554-B1 | CONFECTIONERY COMPOSITIONS | PROCTER & GAMBLE (US) | 2004-06-16 | — | — | EP | claimed |
| EP-0977553-B1 | THROAT SOOTHING COMPOSITIONS | PROCTER & GAMBLE (US) | 2003-09-10 | — | — | EP | claimed |
| US-6432441-B1 | ENCAPSULATION OF ANALGESICS, EXPECTORANTS OR ANTITUSSIVE AGENTS WITHIN PHOSPHATIDES TO PROLONG DRUG DELIVERY | THE PROCTER & GAMBLE COMPANY | 2002-08-13 | — | — | US | claimed |
| US-6306429-B1 | THROAT DROPS SUITABLE FOR RELIEF OF COUGH AND COLD SYMPTOMS | THE PROCTER & GAMBLE COMPANY | 2001-10-23 | — | — | US | claimed |
| EP-0977554-A1 | CONFECTIONERY COMPOSITIONS | THE PROCTER & GAMBLE COMPANY (US) | 2000-02-09 | — | — | EP | claimed |
| EP-0977553-A1 | THROAT SOOTHING COMPOSITIONS | THE PROCTER & GAMBLE COMPANY (US) | 2000-02-09 | — | — | EP | claimed |
| WO-1998047483-A1 | CONFECTIONERY COMPOSITIONS | THE PROCTER & GAMBLE COMPANY (US) | 1998-10-29 | — | — | WO | claimed |
| WO-1998047482-A1 | THROAT SOOTHING COMPOSITIONS | THE PROCTER & GAMBLE COMPANY (US) | 1998-10-29 | — | — | WO | claimed |
| EP-0837862-A1 | WARMING COMPOUNDS | THE PROCTER & GAMBLE COMPANY (US) | 1998-04-29 | — | — | EP | claimed |
| WO-1997002273-A1 | WARMING COMPOUNDS | THE PROCTER & GAMBLE COMPANY (US) | 1997-01-23 | — | — | WO | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11344488-B2 | Cool-sensation imparter composition containing 2,2,6-trimethylcyclohexanecarboxylic acid derivative | CNR2, ADRB2, TRPA1 | FOS 3650/4885TTR 1912/4885JUN 2864/4885 |
| US-11236042-B2 | Methylmenthol derivative and cool-sensation imparter composition containing same | TRPM8, TRPM4, TRPM2 | FOS 3824/4885TTR 3545/4885JUN 3221/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.